A Dose-Ranging, Phase II, Open Label Study of ATN 161 in Advanced Renal Cell Cancer

Trial Profile

A Dose-Ranging, Phase II, Open Label Study of ATN 161 in Advanced Renal Cell Cancer

Discontinued
Phase of Trial: Phase II

Latest Information Update: 05 Dec 2007

At a glance

  • Drugs ATN 161 (Primary)
  • Indications Renal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Nov 2006 Status change
    • 25 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top